CAS: 1275595-86-2
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Selatinib REF: 4Z-S-226001CAS: 1275595-86-2 | - - - | A consultar | Jue 23 Ene 25 |
 | Selatinib REF: 3D-FS180427CAS: 1275595-86-2 | Min. 95% | A consultar | Mar 04 Feb 25 |
 | Lapatinib-d7 Sulfoxide Dihydrochloride REF: TR-L175812CAS: | - - - | 802,00 €~2.388,00 € | Lun 10 Feb 25 |
 | Selatinib REF: TM-T34602CAS: 1275595-86-2 | 98% | 96,00 €~1.847,00 € | Mié 12 Mar 25 |
Ref: 4Z-S-226001
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 23 de Enero de 2025
Selatinib
CAS:1275595-86-2
Selatinib is a pyridine compound that inhibits the tyrosine kinase activity of proteins. Selatinib has …
Fórmula:
C29H26ClFN4O3S
Pureza:
Min. 95%
Peso molecular:
565.1 g/mol
Ref: 3D-FS180427
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Martes 4 de Febrero de 2025
Lapatinib-d7 Sulfoxide Dihydrochloride
Producto controladoApplications Lapatinib-d7 Sulfoxide Dihydrochloride is a by-product during the synthesis of Lapatinib-d7 Dihydrochloride (L175807), a …
Fórmula:
C29H19D7ClFN4O3S· 2(HCl)
Forma y color:
Neat
Peso molecular:
645.02
Ref: TR-L175812
| 25mg | 802,00 € | ||
| 50mg | 1.515,00 € | ||
| 100mg | 2.388,00 € |
Entrega estimada en Estados Unidos, el Lunes 10 de Febrero de 2025
Selatinib
CAS:1275595-86-2
Selatinib is an orally active and potent dual inhibitor of EGFR and ErbB2 with anticancer …
Fórmula:
C29H26ClFN4O3S
Pureza:
98%
Forma y color:
Solid
Peso molecular:
565.06
Ref: TM-T34602
| 1mg | 96,00 € | ||
| 5mg | 229,00 € | ||
| 10mg | 345,00 € | ||
| 25mg | 637,00 € | ||
| 50mg | 926,00 € |
Entrega estimada en Estados Unidos, el Miércoles 12 de Marzo de 2025
